NSE · BSE · Real-time
High-value corporate events — new orders, fund raises, capacity expansions, and earning calls — analysed by AI the moment they hit the exchange.
IOL Chemicals and Pharmaceuticals (IOLCP) has initiated a multi-pronged ₹495 crore expansion strategy at its Barnala facility to solidify its global leadership in Ibuprofen and diversify into higher-margin segments. The plan includes a massive 50% capacity hike for its core Ibuprofen product alongside the launch of new CDMO and specialty chemical verticals.
Real-time NSE & BSE event alerts, AI-summarized filings, and instant order-win signals — free for 15 days, no card required.
